ArticleOncology letters2018
Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma.
Hui-Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it